Olympus Medical Systems India Private Limited commenced its Direct business operation in India from April 1, 2010 with an initial objective to become the most respected, reliable and chosen Brand in healthcare domain in India. Olympus Medical Systems India is a wholly owned subsidiary of Olympus Corporation of Asia Pacific Ltd and have major manufacturing foot prints at Japan and Germany. Through a focussed approach in the market, Olympus has been able to develop a great relationship and visible presence across full spectrum of customer base includes prime education institutes and corporate hospitals in India.
Olympus has a wide portfolio of products that are equipped with the latest innovative and superior technology. Olympus deals primarily in two verticals i.e. Gastrointestinal/ Respiration & Surgical divisions and contribute to the medical society with state of the art product categories that includes, Video Endoscopy, Endoscopic Ultrasound, Bronchoscopy, Endotherapy devices in Gastrointestinal & Respiratory range whereas Surgical division includes High definition imaging system includes 3D & 4K system with high end Energy products to deal with Laproscopy, Genaral surgery, Gynecology and urology field.
OLYMPUS is primarily involved in supporting various training activities to spread awareness among Indian users through its strong marketing team and is committed to continue to participate in such events in future as well.
Olympus has been spending heavily and expanding its sales and service network through state of the art National Service Workshops at Head Office Gurgaon and 8 more locations – qualifying the most stringent protocols followed at Japan, covering the vast geography of India. Olympus has been growing rapidly in India and is committed to dedicate all required sales, service and marketing resources for further growth in such a vibrant emerging market.
ResMed is a global leader in the development, manufacturing and marketing of innovative medical products for the treatment and management of respiratory disorders with a focus on sleep-disordered breathing. ResMed is committed to advancing technology in sleep and respiratory medicine and commercializing innovative products incorporating these technologies on a ¬¬¬¬global basis. An excellent leadership and a team of 5000+ employees with diverse professional, technical, marketing, medical and manufacturing skills, we sell a comprehensive range of products in more than 100 countries worldwide through direct offices and a network of distributors.
Founded by Dr.Peter Farrell, current chairman of Board, in 1989 in Sydney, company now operates from their headquarters in San Diego US, Regional Europe headquarter in Paris and Asia Pacific headquarter in Sydney. ResMed has manufacturing facilities in Australia, Singapore, France and USA and has 3000+ patents/designs issued or pending to its credit. We are committed to creating the world’s best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease and saving healthcare costs.
At ResMed we believe that every breath is an opportunity to make a positive change to people’s lives and we do this with award-winning medical devices and cutting-edge cloud-based software applications that diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. A true global leader in connected care, we have more than 2 million patients remotely monitored every day.
Smith & Nephew Healthcare
As a 160 years old UK-headquartered medical devices manufacturer and multinational organization, Smith & Nephew supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients.
We are one of the global leaders in:
- Orthopaedics Reconstruction – joint replacement systems for knees, hips and shoulders
- Advanced Wound Management – wound care treatment and prevention products used to treat hard-to-heal wounds
- Sports Medicine – minimally invasive surgery of the joints
- Trauma & Extremities – products that help repair fractures and deformities
With our annual sales of close to 4.6 billion USD (2015), we have around 15,000 employees around the world, who embody Innovation, Trust and Performance as the core values of Smith & Nephew.
We are a constituent of the UK’s FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange.
Smith & Nephew has frequently made it to the Forbes’ list of the World’s 100 Most Innovative Companies (2013, 2015, 2016).
Smith & Nephew takes a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems. Our recent initiatives include the launch of our mid-tier value segment of products in orthopedics and wound management (which includes the legacy range of our acquired Sushrut-Adler business in India), acquisitions of Arthrocare (to strengthen our performance in Sports Medicine) and Blue Belt Technologies (giving us a leading position in the fast-growing area of robotics-assisted orthopaedic surgery). In addition, we make major investments in R&D as well as Educational platforms and Evidence generation, which have been our major drivers in India and emerging markets, where providing affordable quality healthcare, training and product and business model innovations are the key to growth.
A testament to the positive difference that we have made is our recent recognition (2016) by the Economic Times as one of the Best Healthcare Brands in India.
At Smiths Medical, our purpose is to provide innovative solutions and superior support to help healthcare professionals and providers ensure safety, enhance patient outcomes, and improve the total cost of care.
At Smiths Medical, we are passionate about improving and saving the lives of patients through high quality, innovative medical devices and services. We are a leading global manufacturer of specialty medical devices that provides innovative and lifesaving solutions for the world’s healthcare markets. Specializing in Infusion Therapy, Vascular Access, Vital Care, and Specialty Products & Services, our products are found in hospital, emergency, home and specialty care environments and are used during critical and intensive care, surgery, post-operative care and for support in managing chronic illness. We have operations in over 30 countries with manufacturing concentrated in the US, UK, Mexico, Italy, Germany, Czech Republic, and China. We sell to approximately 120 markets and, while the US continues to be our largest single market with around 45% of sales, we continue to build our presence in developing and emerging markets.
Our Product Portfolio includes:
- Infusion Therapy – Fluid and medication delivery devices for pain management and the treatment of acute and chronic diseases.
- Vital Care – Devices for managing patients’ airways and body temperature before, during and after surgery.
- Vascular Access – Devices providing healthcare professionals access to patients’ vasculature for delivery and withdrawal of fluid and medication, as well as devices to protect health workers by helping prevent needlestick injuries.
- Speciality Products & Services – Products for clinicians and businesses in the specialized care areas of in vitro diagnostics and fertilization, veterinary health, transport ventilation, patient monitoring and medical device manufacturing.
Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
At Stryker, quality is first in everything we do. We are driven to make healthcare better for our customers by providing innovative products and services that meet regulatory requirements through our effective quality system.
We believe the health of the world is as important as the people who live in it. We are committed to making responsible decisions that help people and preserve the planet for future generations.